Our observation that tirzepatide use was associated with PDR but not with diabetic macular oedema is consistent with recent large post-marketing studies of GLP-1RA use [22]
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: a first-in-class, first-in-human study
PMID: 27261637, PMCID: PMC5305177, DOI: 10.1097/mlr.0000000000000571
"I wrecked my knees and my feet because all I would do is put in headphones and run
Step #4
Though he believes more research must be done, Rong Xu, the studys lead researcher and a professor of biomedical informatics at the Case Western Reserve University School of Medicine, said the results are very promising news in that we may have a new therapeutic method to treat AUD. Get Forbes Breaking News Text Alerts: Were launching text message alerts so you'll always know the biggest stories shaping the days headlines